Clinical Trials

Glioblastoma Multiforme (GBM)

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 3 of 3 Clinical Trials Related to Glioblastoma Multiforme (GBM)

NRG-BN011

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Doctor(s) Running This Study

NRG BN007

A Randomized Phase II/III Open-label Study of Ipilimumab and Nivolumab vs Temozolomide in Patients with Newly Diagnosed MGMT Unmethylated Glioblastoma

Doctor(s) Running This Study

MSK 18-400 Glioblastoma

A Phase II Trial of the PD-1 Antibody Nivolumab in Combination with Hypofractionated Re-irradiation and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Doctor(s) Running This Study